BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

973 related articles for article (PubMed ID: 28595649)

  • 1. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
    Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
    BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
    Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
    Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database.
    Egger T; Dormann H; Ahne G; Runge U; Neubert A; Criegee-Rieck M; Gassmann KG; Brune K
    Drugs Aging; 2003; 20(10):769-76. PubMed ID: 12875612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items.
    Kovačević M; Vezmar Kovačević S; Radovanović S; Stevanović P; Miljković B
    Curr Med Res Opin; 2019 Nov; 35(11):1873-1883. PubMed ID: 31328967
    [No Abstract]   [Full Text] [Related]  

  • 5. Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database.
    Magro L; Arzenton E; Leone R; Stano MG; Vezzaro M; Rudolph A; Castagna I; Moretti U
    Front Pharmacol; 2020; 11():622862. PubMed ID: 33536925
    [No Abstract]   [Full Text] [Related]  

  • 6. A 6-year retrospective study of adverse drug reactions due to drug-drug interactions between nervous system drugs.
    Shi QP; He XD; Yu ML; Zhu JX; Liu Y; Ding F; Sang R; Jiang XD; Zhang SQ
    Int J Clin Pharmacol Ther; 2014 May; 52(5):392-401. PubMed ID: 24691061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug-Drug Interactions: An Analysis From the French Pharmacovigilance Database.
    Létinier L; Ferreira A; Marceron A; Babin M; Micallef J; Miremont-Salamé G; Pariente A;
    Front Pharmacol; 2020; 11():624562. PubMed ID: 33841134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR Modeling and Prediction of Drug-Drug Interactions.
    Zakharov AV; Varlamova EV; Lagunin AA; Dmitriev AV; Muratov EN; Fourches D; Kuz'min VE; Poroikov VV; Tropsha A; Nicklaus MC
    Mol Pharm; 2016 Feb; 13(2):545-56. PubMed ID: 26669717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of three drug-drug interaction screening systems against probable clinically relevant drug-drug interactions: a prospective cohort study.
    Muhič N; Mrhar A; Brvar M
    Eur J Clin Pharmacol; 2017 Jul; 73(7):875-882. PubMed ID: 28299402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).
    Tavassoli N; Sommet A; Lapeyre-Mestre M; Bagheri H; Montrastruc JL
    Drug Saf; 2007; 30(11):1063-71. PubMed ID: 17973542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning workflow to enhance predictions of Adverse Drug Reactions (ADRs) through drug-gene interactions: application to drugs for cutaneous diseases.
    Raja K; Patrick M; Elder JT; Tsoi LC
    Sci Rep; 2017 Jun; 7(1):3690. PubMed ID: 28623363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mining heterogeneous networks with topological features constructed from patient-contributed content for pharmacovigilance.
    Yang CC; Yang H
    Artif Intell Med; 2018 Aug; 90():42-52. PubMed ID: 30093253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
    Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E
    Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting adverse drug reactions of combined medication from heterogeneous pharmacologic databases.
    Zheng Y; Peng H; Zhang X; Zhao Z; Yin J; Li J
    BMC Bioinformatics; 2018 Dec; 19(Suppl 19):517. PubMed ID: 30598065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Label Propagation Prediction of Drug-Drug Interactions Based on Clinical Side Effects.
    Zhang P; Wang F; Hu J; Sorrentino R
    Sci Rep; 2015 Jul; 5():12339. PubMed ID: 26196247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study.
    Obreli-Neto PR; Nobili A; de Oliveira Baldoni A; Guidoni CM; de Lyra Júnior DP; Pilger D; Duzanski J; Tettamanti M; Cruciol-Souza JM; Gaeti WP; Cuman RK
    Eur J Clin Pharmacol; 2012 Dec; 68(12):1667-76. PubMed ID: 22644345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France.
    Montastruc F; Sommet A; Bondon-Guitton E; Durrieu G; Bui E; Bagheri H; Lapeyre-Mestre M; Schmitt L; Montastruc JL
    Eur J Clin Pharmacol; 2012 May; 68(5):767-75. PubMed ID: 22116460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SignalDetDDI: An SAS macro for detecting adverse drug-drug interactions in spontaneous reporting systems.
    Gosho M; Ohigashi T; Maruo K
    PLoS One; 2018; 13(11):e0207487. PubMed ID: 30452488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.